Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
Holding EKSO?
Track your performance easily
EKSO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.62 - $3.13
Previous Close$1.23
Volume23.03K
Average Volume (3M)88.54K
Market Cap
$25.85M
Enterprise Value$27.31M
Total Cash (Recent Filing)$5.88M
Total Debt (Recent Filing)$6.69M
Price to Earnings (P/E)―
Beta1.51
Next Earnings
Oct 31, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.79
Shares Outstanding18,444,181
10 Day Avg. Volume78,519
30 Day Avg. Volume88,536
Standard Deviation0.27
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.89
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.50
Enterprise Value/Gross Profit3.01
Enterprise Value/Ebitda-2.64
Forecast
1Y Price Target
$6.25Price Target Upside420.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EKSO BIONICS News
Bulls Say, Bears Say
Bulls Say
Analyst RatingAnalyst maintains a Buy rating of EKSO and sets a new 12-month price target, based on various valuation methods.
Market ExpansionThe revenue decline in North America was partially offset by revenues from international markets, especially the EMEA region, driven by increased adoption in France.
New Reimbursement PoliciesThe Centers for Medicare and Medicaid Services finalized the reimbursement price for the Ekso Indego Personal, which could aid in increasing adoption of the device.
Bears Say
Earnings MissThe company's revenue fell short of expectations, reporting $3.8M against an estimate of $5.0M.
Reimbursement DelayThe Centers for Medicare & Medicaid Services has postponed deciding on a reimbursement rate for Indego Personal, impacting future revenue projections.
Year-over-Year DeclineEkso's total revenue saw a 9% drop from the previous year, decreasing from $4.1M to $3.8M.
---
Ownership Overview
79.99% Insiders
3.28% Mutual Funds
6.05% Other Institutional Investors
10.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
EKSO FAQ
What was EKSO BIONICS’s price range in the past 12 months?
EKSO BIONICS lowest stock price was $0.62 and its highest was $3.13 in the past 12 months.
What is EKSO BIONICS’s market cap?
Currently, no data Available
When is EKSO BIONICS’s upcoming earnings report date?
EKSO BIONICS’s upcoming earnings report date is Oct 31, 2024 which is in 36 days.
How were EKSO BIONICS’s earnings last quarter?
EKSO BIONICS released its earnings results on Jul 29, 2024. The company reported -$0.13 earnings per share for the quarter, the consensus estimate of -$0.13 by $0.
Is EKSO BIONICS overvalued?
According to Wall Street analysts EKSO BIONICS’s price is currently Undervalued.
Does EKSO BIONICS pay dividends?
EKSO BIONICS does not currently pay dividends.
What is EKSO BIONICS’s EPS estimate?
EKSO BIONICS’s EPS estimate is -$0.11.
How many shares outstanding does EKSO BIONICS have?
EKSO BIONICS has 21,544,182 shares outstanding.
What happened to EKSO BIONICS’s price movement after its last earnings report?
EKSO BIONICS reported an EPS of -$0.13 in its last earnings report, expectations of -$0.13. Following the earnings report the stock price went down -28.378%.
Which hedge fund is a major shareholder of EKSO BIONICS?
Currently, no hedge funds are holding shares in EKSO
---
EKSO BIONICS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.25 (420.83% Upside)
$6.25 (420.83% Upside)
Blogger Sentiment
Bullish
EKSO Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 5.3%
Last 30 Days ▲ 5.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
78.26%
12-Months-Change
Fundamentals
Return on Equity
-83.20%
Trailing 12-Months
Asset Growth
-20.60%
Trailing 12-Months
Company Description
EKSO BIONICS
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
EKSO Earnings Call
Q2 2024
0:00 / 0:00
---
EKSO Stock 12 Month Forecast
Average Price Target
$6.25
▲(420.83% Upside)
Technical Analysis
Best Analysts Covering EKSO
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-20.33%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -20.33% per trade.
---